Literature DB >> 2068318

Renal atrophy or infarction in children with neuroblastoma.

D L Day1, R T Johnson, G T Odrezin, W G Woods, B A Alford.   

Abstract

Twelve children with adrenal or upper abdominal paraaortic neuroblastoma developed unilateral or bilateral renal atrophy or infarction. At presentation, the children ranged in age from 2 weeks to 9.7 years. Neuroblastomas were stage II (n = 1), III (n = 2), IV-S (n = 2), and IV (n = 7). Treatment varied but included surgery, chemotherapy, localized abdominal irradiation, and/or bone marrow transplantation. Six children developed ipsilateral renal atrophy, five experienced ipsilateral or bilateral acute perioperative renal infarction, and one developed contralateral renal infarction unrelated to surgery. During treatment, two patients required hemodialysis; both subsequently died. Creatinine concentrations in eight patients have been in the normal range. Two patients have had mildly but persistently elevated creatinine levels. Renal damage from primary effects of the tumor can develop in children with adrenal or upper abdominal neuroblastoma. Treatment, especially surgical resection of the primary tumor, chemotherapy, and radiation therapy, can compound such damage.

Entities:  

Mesh:

Year:  1991        PMID: 2068318     DOI: 10.1148/radiology.180.2.2068318

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Intraoperative radiation therapy for advanced neuroblastoma: the problem of securing the IORT field.

Authors:  Kiminobu Sugito; Takeshi Kusafuka; Mayumi Hoshino; Mikiya Inoue; Hiroshi Goto; Taro Ikeda; Noritsugu Hagiwara; Tsugumichi Koshinaga; Masahiro Fukuzawa; Masanori Nakamura; Hiroyuki Shichino; Motoaki Chin; Hideo Mugishima; Tsutomu Saito; Yoshiaki Tanaka
Journal:  Pediatr Surg Int       Date:  2007-10-30       Impact factor: 1.827

2.  Intravenous digital subtraction angiography for the evaluation of renal artery blood flow following the removal of a neuroblastoma.

Authors:  I Yamagiwa; K Obata; H Saito; M Washio
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.